165 related articles for article (PubMed ID: 36848533)
41. Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients.
Schorb E; Finke J; Ihorst G; Kasenda B; Fricker H; Illerhaus G
BMC Cancer; 2019 Mar; 19(1):287. PubMed ID: 30925912
[TBL] [Abstract][Full Text] [Related]
42. Central Nervous System Prophylaxis Strategies in Diffuse Large B Cell Lymphoma.
Kansara R
Curr Treat Options Oncol; 2018 Sep; 19(11):52. PubMed ID: 30203318
[TBL] [Abstract][Full Text] [Related]
43. Integrin alpha 10, CD44, PTEN, cadherin-11 and lactoferrin expressions are potential biomarkers for selecting patients in need of central nervous system prophylaxis in diffuse large B-cell lymphoma.
Lemma SA; Kuusisto M; Haapasaari KM; Sormunen R; Lehtinen T; Klaavuniemi T; Eray M; Jantunen E; Soini Y; Vasala K; Böhm J; Salokorpi N; Koivunen P; Karihtala P; Vuoristo J; Turpeenniemi-Hujanen T; Kuittinen O
Carcinogenesis; 2017 Aug; 38(8):812-820. PubMed ID: 28854563
[TBL] [Abstract][Full Text] [Related]
44. A Rare Presentation of Primary Central Nervous System Lymphoma in an Immunocompetent Patient.
DeRon N; Ahmed M; Lopez D; Alobaidi A
Cureus; 2022 Apr; 14(4):e23858. PubMed ID: 35530884
[TBL] [Abstract][Full Text] [Related]
45. Inflammatory brain lesions preceding primary central nervous system lymphoma: a case report and genetic analysis.
XiaoHong Z; Shuo Y; GeHong D; AnChao Y; Ce W; YunYun D; Can W; SiJie H; Feng C; WenBin L
Neurol Sci; 2023 May; 44(5):1555-1561. PubMed ID: 36599976
[TBL] [Abstract][Full Text] [Related]
46. Clinical and histological features of primary testicular diffuse large B-cell lymphoma: a single center experience in China.
Zhou D; Bao C; Ye X; Zhu L; Zhu J; Li L; Zhu M; Yang X; Zheng Y; Huang X; Xie M; Xie W
Oncotarget; 2017 Dec; 8(68):112384-112389. PubMed ID: 29348832
[TBL] [Abstract][Full Text] [Related]
47. (11)C-methionine PET/CT and MRI of primary central nervous system diffuse large B-cell lymphoma before and after high-dose methotrexate.
Jang SJ; Lee KH; Lee JY; Choi JY; Kim BT; Kim SJ; Kim WS
Clin Nucl Med; 2012 Oct; 37(10):e241-4. PubMed ID: 22955084
[TBL] [Abstract][Full Text] [Related]
48. Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
Mappa S; Marturano E; Licata G; Frezzato M; Frungillo N; Ilariucci F; Stelitano C; Ferrari A; Sorarù M; Vianello F; Baldini L; Proserpio I; Foppoli M; Assanelli A; Reni M; Caligaris-Cappio F; Ferreri AJ
Hematol Oncol; 2013 Sep; 31(3):143-50. PubMed ID: 23161567
[TBL] [Abstract][Full Text] [Related]
49. Cutaneous metastasis of primary diffuse large B-cell lymphoma of the central nervous system developing 4 years after complete remission: Diagnosis confirmed by comparison of clones.
Patel BM; Moesch J; Karunamurthy A; Puleio DV; Drappatz J; Akilov OE; Kazlouskaya V
J Cutan Pathol; 2022 Jan; 49(1):90-94. PubMed ID: 34498750
[TBL] [Abstract][Full Text] [Related]
50. [Clinical manifestation and treatment of extranodal diffuse large B-cell lymphoma].
Tomita N
Rinsho Ketsueki; 2016; 57(10):1991-1999. PubMed ID: 27725597
[TBL] [Abstract][Full Text] [Related]
51. Systems biology of primary CNS lymphoma: from genetic aberrations to modeling in mice.
Deckert M; Montesinos-Rongen M; Brunn A; Siebert R
Acta Neuropathol; 2014 Feb; 127(2):175-88. PubMed ID: 24240734
[TBL] [Abstract][Full Text] [Related]
52. Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab.
Tai WM; Chung J; Tang PL; Koo YX; Hou X; Tay KW; Quek R; Tao M; Lim ST
Ann Hematol; 2011 Jul; 90(7):809-18. PubMed ID: 21229246
[TBL] [Abstract][Full Text] [Related]
53. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
[TBL] [Abstract][Full Text] [Related]
54. Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrence.
Magnes T; Wagner S; Thorner AR; Neureiter D; Klieser E; Rinnerthaler G; Weiss L; Huemer F; Zaborsky N; Steiner M; Weis S; Greil R; Egle A; Melchardt T
ESMO Open; 2021 Feb; 6(1):100012. PubMed ID: 33399078
[TBL] [Abstract][Full Text] [Related]
55. Clinical Effect of CD25 on the Prognosis of Diffuse Large B Cell Lymphoma with Secondary Central Nervous System Relapse.
Oka S; Ono K; Nohgawa M
Pathol Oncol Res; 2020 Jul; 26(3):1843-1850. PubMed ID: 31768966
[TBL] [Abstract][Full Text] [Related]
56. Prophylaxis strategies containing high dose intravenous methotrexate on preventing CNS relapse for patients with diffuse large B-cell lymphoma at intermediate to high risk: A study based on 12 cohorts in the rituximab era.
Zhang N; Xu D; Liu B; Shi X; Xie X; Wang Z
Int Immunopharmacol; 2022 Dec; 113(Pt A):109299. PubMed ID: 36252471
[TBL] [Abstract][Full Text] [Related]
57. Primary central nervous system lymphoma in Korea: comparison of B- and T-cell lymphomas.
Choi JS; Nam DH; Ko YH; Seo JW; Choi YL; Suh YL; Ree HJ
Am J Surg Pathol; 2003 Jul; 27(7):919-28. PubMed ID: 12826884
[TBL] [Abstract][Full Text] [Related]
58. Analysis of Key Factors Associated with Response to Salvage High-Dose Methotrexate Rechallenge in Primary Central Nervous System Lymphoma with First Relapse.
Du P; Chen H; Shen L; Liu X; Wu X; Chen L; Cao A; Geng D
Curr Oncol; 2022 Sep; 29(9):6642-6656. PubMed ID: 36135091
[TBL] [Abstract][Full Text] [Related]
59. Similar chemokine receptor profiles in lymphomas with central nervous system involvement - possible biomarkers for patient selection for central nervous system prophylaxis, a retrospective study.
Lemma SA; Pasanen AK; Haapasaari KM; Sippola A; Sormunen R; Soini Y; Jantunen E; Koivunen P; Salokorpi N; Bloigu R; Turpeenniemi-Hujanen T; Kuittinen O
Eur J Haematol; 2016 May; 96(5):492-501. PubMed ID: 26153511
[TBL] [Abstract][Full Text] [Related]
60. Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies.
Hernández-Verdin I; Morales-Martínez A; Hoang-Xuan K; Alentorn A
Curr Opin Neurol; 2022 Dec; 35(6):779-786. PubMed ID: 36367044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
